No Data
No Data
Kringle Pharma Releases New Analyst Report
Kringle Pharma: Confirmation
Kringle Pharma: Financial Report - 23rd Term (2023/10/01 - 2024/09/30)
Scars Therapeutics Pipeline Report 2024: Insights About 8+ Companies and 10+ Drugs Featuring Kringle Pharma, Innovo Therapeutics, CellinCells, CellionBioMed, and Syntara
Kringle Pharma: Question and answer session on full-year financial results Earnings Conference year ending September 2024
Allied-Axis, etc. [Stocks with attractive valuations viewed from volume changes]
Stock closing price previous day comparison volume * <6977> Nichi Resistor 950150249800 * <9236> Japan M&A 1116150298300 * <6081> Allied Arc 18121010300 * <4884> Cringler 904124801500 * <4644> Imaginia 10383681900 * <7445> Light On 2065751600 * <4381> B Platts 6222573400